A New Dawn of Psychedelic Therapy
The New Orchard, December 4, 2024
In this podcast episode, our Executive Director Tania de Jong AM, shares her journey as one of Australia’s most influential entrepreneurs and changemakers. This conversation highlights Tania’s pivotal work with the TGA and the successful campaign to legalise psilocybin and MDMA-assisted therapy in Australia, a landmark moment for mental health care. Tune in to learn more about the movement transforming lives through psychedelic-assisted therapies.
JJ’s genes: Son of Lululemon founder ships first load of legal psilocybin to Australia
Forbes, August 21, 2024
Legal suppliers of psilocybin and MDMA are rushing to meet the market following Australia’s recent approval of their clinical use.
Optimi Health Completes Inaugural Export of MDMA Capsules to Australia for PTSD Treatment
Newsfile, August 16, 2024
Optimi Health Corp, a GMP-approved, Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in botanical psilocybin and MDMA, is pleased to announce it has completed the inaugural export of it’s GMP-validated MDMA capsules to Australia for the treatment of PTSD, along with a series of notable corporate developments.
Psychedelics as a serious in investment? These billionaires think so
AFR, August 9, 2024
Australia is among the first countries to use the drugs for treating anxiety, depression and PTSD. A decision in the United States could be pivotal. Australia became the first country to legalise the medical use of psychedelics when the Therapeutic Goods Administration announced changes to the scheduling of psilocybin and MDMA in February last year.
Mental Health Emergency
Australian Life Magazine, August 1, 2024
There is no question that the deteriorating mental health of Australians has been brought to the forefront of the national conversation as one of the sad consequences of the response to COVID-19.
Doubt it not, MDMA is a medicine
Mind Medicine Australia, Drug Science UK and Parea, June 21, 2024
The recent rejection of MDMA-assisted therapy for PTSD by the FDA Psychopharmacologic Drugs Advisory Committee (AdCom) was surprising to many working in the field of mental illness.
Adam’s son died in the Hunter Valley bus crash. In a NSW first, he’ll try MDMA to ease his anguish
The Sydney Morning Herald, June 3, 2024
Associate professor Ranil Gunewardene, who is a psychiatrist and director of Evolution: Medicine Enhanced Therapy, has been approved by the TGA’s authorised prescriber scheme to run the first treatment service and research study in NSW.
Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment
Mugglehead Magazine, May 31, 2024
British Columbia’s psychedelics and natural health products company Optimi Health Corp. (CSE: OPTI) has been making significant progress toward achieving its international distribution goals.
This week, the company obtained a permit to send MDMA and psilocybin capsules to the non-profit charity organization Mind Medicine Australia.
Tania de Jong AM Interview about Psychedelic-Assisted Therapies on 6PR
6PR, May 30, 2024
Tania de Jong AM, Executive Director of Mind Medicine Australia, is interviewed about psychedelic-assisted therapies in Australia.
Psychedelics import deal struck as activists move ahead of regulators
The Australian, May 29, 2024
A deal that paves the way for Australia’s biggest importation of psychedelic medicines has been struck by a charity pushing the therapy, with a Canadian manufacturer pledging to “provide financial assistance to marginalised Australians” to help them access MDMA and psilocybin.
Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules
Globe News Wire, May 29, 2024
Company preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.
Is it now time to prepare psychiatry for a psychedelic future?
British Journal of Psychiatry, May 20, 2024
“Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.”
Psychedelic-Assisted therapies Treating Trauma
Australian Jewish News, May 17, 2024
An Australian doctor recently became the first in the world to treat a patient with a controlled dose of MDMA, putting Australia at the forefront of the emerging field of psychedelics.
MDMA Therapy In Australia: Making History One Prescription at a Time
Psychedelics.com, March 25, 2024
On a remarkable day in January 2024, the field of mental health witnessed a history-making moment: the first prescription of MDMA for a patient with chronic, treatment-resistant PTSD outside of a trial setting.
NSW Mental Health Minister Rose Jackson acknowledges calls for NSW to expand psilocybin, MDMA treatments
The Australian, March 14, 2024
NSW Mental Health Minister Rose Jackson has conceded more needs to be done to allow people suffering from severe mental health conditions to access emerging therapies such as MDMA and psilocybin.
The Healing Powers of Magic Mushrooms and MDMA: Psychedelic-Assisted Therapies for the Treatment of PTSD and Depression
All About You Podcast, March 3, 2024
On this episode of the All About You Podcast, Tania de Jong AM shares about our work with Mind Medicine Australia and the healing powers of these treatments.
Aussie doctor becomes first to prescribe medicinal MDMA
9 News Australia, February 11, 2024
An Australian doctor has become the talk of the medical world after becoming the first to prescribe MDMA for the treatment of post-traumatic stress disorder.
An Australian doctor has just made global history. This is what happened
The Age, February 7, 2024
A single pill administered in a borrowed medical clinic has become the talk of mental health doctors around the world. Ted Cassidy’s patient took a capsule containing a drug known by recreational users as ecstasy, but which was approved for prescription in its pure form by Australian regulators last year – for the first time ever, anywhere – to assist therapy for sufferers of complex post-traumatic stress disorder. It was one of the first dosages in Australia, alongside another given by Victorian psychiatrist Eli Kotler the same week.
Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne
Mugglehead Magazine, February 4, 2024
Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month
Caution over psychedelic meds in new approach to trauma
Yahoo! News, February 3, 2024
Melbourne psychiatrist and MMA Board Member, Dr Eli Kotler is among a handful of Australian doctors able to prescribe psychedelic medication in limited circumstances.